<unk> (ophthalmic) is a beta-Adrenergic Blocker that is FDA approved for the treatment of chronic open-angle glaucoma and intraocular hypertension.   Common adverse reactions include angina, asthenia, dizziness, headache, insomnia, blurred vision, burning sensation in eye, conjunctival edema, conjunctival hyperemia, epiphora, and eye irritation.
Carteolol 
Bevantolol
Nadolol 
Alprenolol
Imolamine
Oxprenolol
Endralazine
Tertatolol